6.75
price up icon4.98%   0.32
after-market Handel nachbörslich: 6.78 0.03 +0.44%
loading

Contineum Therapeutics Inc Aktie (CTNM) Neueste Nachrichten

pulisher
Aug 12, 2025

Contineum Therapeutics Inc. stock trend forecastHigh Accuracy Trade Setup Identification - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Price momentum metrics for Contineum Therapeutics Inc. explainedAI Model Forecasting Reversal and Breakout Zones - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

How to use a screener to detect Contineum Therapeutics Inc. breakoutsMarket Timing Strategy with Technical Filters - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Is Contineum Therapeutics Inc. stock entering bullish territoryMonthly Long-Term Market Recap and Summary - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Long term hold vs stop loss in Contineum Therapeutics Inc.Momentum Stocks with Breakout Potential - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

Using portfolio simulators with Contineum Therapeutics Inc. includedFree Fast Gaining Stock Screener Report - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Applying Elliott Wave Theory to Contineum Therapeutics Inc.Entry Zone Watchlist With Momentum Focus - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

What data driven models say about Contineum Therapeutics Inc.’s futureFree Expert Verified Stock Trade Ideas - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Why Contineum Therapeutics Inc. stock attracts strong analyst attentionHigh Win Rate Strategy with Stop Protection - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

How high can Contineum Therapeutics Inc. stock goCapital Safe Picks with Consistent Gains - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Wall Street Analysts Think Contineum Therapeutics, Inc. (CTNM) Could Surge 235.81%: Read This Before Placing a Bet - MSN

Aug 10, 2025
pulisher
Aug 10, 2025

Earnings visualization tools for Contineum Therapeutics Inc.Sector-Wise Equity Performance Trend Forecast - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Developing predictive dashboards with Contineum Therapeutics Inc. dataInvestment Roadmap for High Potential Stocks - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

What makes Contineum Therapeutics Inc. stock price move sharplyCommunity Picked Stocks with Trade Insights - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Technical signs of recovery in Contineum Therapeutics Inc.Free Early Entry Tips With Low Risk Zone - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

How Contineum Therapeutics Inc. stock reacts to Fed policy changesStock Trading Session Highlights and Summary - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Published on: 2025-08-09 23:35:16 - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

Has Contineum Therapeutics Inc. Stock Ever Crashed Historical Volatility ReviewFree Smart Money Tracking Signal Generator - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Contineum Therapeutics, Inc. (NASDAQ:CTNM) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Aug 09, 2025
pulisher
Aug 09, 2025

William Blair Analysts Boost Earnings Estimates for CTNM - Defense World

Aug 09, 2025
pulisher
Aug 08, 2025

Will earnings trigger a reversal in Contineum Therapeutics Inc.Day Trading Setup and Momentum Analysis - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Contineum (CTNM) Q2 R&D Jumps 78% - AOL.com

Aug 08, 2025
pulisher
Aug 08, 2025

After losing 59% in the past year, Contineum Therapeutics, Inc. (NASDAQ:CTNM) institutional owners must be relieved by the recent gain - simplywall.st

Aug 08, 2025
pulisher
Aug 07, 2025

Strategies to average down on Contineum Therapeutics Inc.Daily Market Momentum Summary and Strategy - Newser

Aug 07, 2025
pulisher
Aug 06, 2025

Contineum reroutes pipeline, funneling cash from MS to lung disease as it eyes showdown with BMS - Fierce Biotech

Aug 06, 2025
pulisher
Aug 06, 2025

RBC Cuts Price Target on Contineum Therapeutics to $25 From $31, Keeps Outperform, Speculative Risk - MarketScreener

Aug 06, 2025
pulisher
Aug 06, 2025

Contineum Therapeutics Reports Second-Quarter 2025 Financial Results; Updates Key Clinical Development Milestones - BioSpace

Aug 06, 2025
pulisher
Aug 05, 2025

Contineum (CTNM) Q2 R&D Jumps 78% - The Motley Fool

Aug 05, 2025
pulisher
Aug 05, 2025

Contineum Therapeutics, Inc. SEC 10-Q Report - TradingView

Aug 05, 2025
pulisher
Aug 05, 2025

Contineum Therapeutics Updates Clinical Development Milestones and Reports Q2 2025 Financial Results. - AInvest

Aug 05, 2025
$35.86
price down icon 0.91%
$81.61
price up icon 3.06%
$25.68
price down icon 9.08%
$122.00
price up icon 8.07%
$111.00
price up icon 1.59%
biotechnology ONC
$288.10
price down icon 0.57%
Kapitalisierung:     |  Volumen (24h):